Thyroid C-cell Tumors: In rodent studies, semaglutide has been demonstrated to trigger thyroid C-cell tumors. It is actually unfamiliar whether or not this risk applies to humans, but semaglutide is contraindicated in sufferers with a personal or relatives heritage of medullary thyroid carcinoma (MTC) or patients with Several Endocrine Neoplasia sy